Skip to content
Menu

Arrowhead Pharmaceuticals, Inc. ARWR

Full chart Compare
Set alert

Price alert · ARWR

All alert types
44.21 USD -3.57 (-7.47%)

Regular-session close

44.70 +0.49 +1.11%

Pre-market · Nov 17, 8:23 AM ET

44.07 Day range 47.41
37.06 52-week range 95.49
YTD
-33.41%
1 year
+7.15%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$6.78MGross Profit$449.02MNet Loss$724.21MCost of Revenue$1.80MExpenses$1.18BSelling, General & Admin$202.04MResearch & Development$739.14MOther Operating Expenses$215.00MOther Expenses$23.82MRevenue$450.82M

Latest period ending Sep 30, 2026 · select a line to chart its full history

ARWR annual income statement
Fiscal yearFY 2026 Sep 30, 2026FY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022
450.82M829.45M3.55M240.74M243.23M
449.02M829.45M3.55M240.74M243.23M
-707.17M98.35M-601.08M-205.00M-178.51M
-724.21M-1.63M-599.49M-205.28M-176.06M
-5.11-0.01-5.00-1.92-1.67
ARWR annual balance sheet
Fiscal yearFY 2026 Sep 30, 2026FY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022
62.73M226.55M102.69M110.89M108.00M
1.74B1.39B1.14B765.55M691.94M
1.69B881.88M948.74M478.39M273.60M
1.40B733.68M851.91M383.50M81.58M
50.31M466.05M185.44M271.34M398.52M
ARWR annual cash flow
Fiscal yearFY 2026 Sep 30, 2026FY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022
-271.95M179.55M-462.85M-153.89M-136.13M
-670.48M-129.29M-420.07M-96.16M-5.42M
776.82M74.01M870.52M253.05M65.19M
-227.00M-22.67M-141.47M-176.74M-52.78M
-165.61M124.26M-12.40M3.01M-76.36M